Emma C. Morris - Dissemin

Papers authored by Emma C. Morris

This paper is made freely available by the publisher.

2009 Michela Cesco-Gaspere, Emma Morris

, Hans J. Stauss

Immunomodulation in the treatment of haematological malignancies

Download from link.springer.com

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

A. Holroyd, W. Townsend, P. Naik, S. Mackinnon, D. Howell, A. Goldstone, D. Linch, K. Peggs, K. Thomson, Mervyn Singer, Emma C. Morris

Favourable outcome for allogeneic haematopoietic transplant recipients requiring intensive therapy unit admission with improved survival following reduced intensity conditioning

Upload

Mark Lowdell, Emma C. Morris

, M. F. Murphy, D. H. Pamphilon

Recent advances in in clinical cellular immunotherapy

Upload

C. Pospori, M. Cesco Gaspere, S. Xue, C. Voisine, M. Perro, A. Holler, G. Wright, Hans J. Stauss, Emma C. Morris

WT1-TCR gene transfer into HSCs: a tumour immunotherapy model

Upload

2008 Kirsty J. Thomson, Emma C. Morris

, Adrian Bloor, Gordon Cook, Donald W. Milligan, Anne Parker, Fiona Clark, Lynny Yung, David C. Linch, Ronjon Chakraverty, Karl S. Peggs, Stephen Mackinnon

Favorable Long-Term Survival After Reduced-Intensity Allogeneic Transplantation for Multiple-Relapse Aggressive Non-Hodgkin's Lymphoma

Download from doi.org

Guillermo Orti, Karl Peggs, Kirsty Thomson, Emma C. Morris

, Mark Lowdell, Stephen Mackinnon, Ronjon Chakraverty

Phase I Study of Transfer of CD8 Depleted Donor Leukocytes after Allogencic Stem Cell Transplantation.

Upload

Aj Mead, Kj Thomson, Ec Morris

, Ronjon Chakraverty, Dc Linch, Stephen Mackinnon, Ks Peggs

Mismatch at 1-2 HLA Loci Does Not Reduce Survival Following Alemtuzumab-Based Reduced Intensity Unrelated Donor Allogeneic Transplantation

Upload

This paper was not found in any repository, but could be made available legally by the author.

M. Perro, S. A. Xue, J. Tsang, M. Cesco-Gaspere, D. Escors, M. Collins, E. Morris

, H. Stauss

Lentiviral TCR gene transfer for adoptive immunotherapy of cancer

Upload

S. Mackinnon, Ec Morris

, A. Bloor, G. Cook, D. Milligan, A. Parker, C. Craddock, L. Yung, Dc Linch, Rk Chakraverty, Ks S. Peggs, Kj J. Thomson

Excellent long-term survival following reduced intensity allogeneic transplantation for multiply relapsed follicular lymphoma

Upload

S. Mackinnon, Ec Morris

, A. Bloor, G. Cook, D. Milligan, A. Parker, C. Craddock, L. Yung, Dc Linch, Rk Chakraverty, Ks S. Peggs, Kj J. Thomson

Favourable long-term survival following reduced intensity allogeneic transplantation for multiply relapsed aggressive non-Hodgkins lymphoma

Upload

Pd D. Kottaridis, K. Thomson, Ak K. Fielding, Emma C. Morris

, R. Chakraverty, K. Peggs, S. Mackinnon

Successful salvage of high risk/relapsed AML with T-cell depleted allogeneic transplant: comparable outcome to standard risk disease even with the use of unrelated donors

Upload

D. P. Hart, S. Thomas, S. Xue, Hans J. Stauss, Emma C. Morris

LMP2-specific TCR gene therapy for Hodgkin's lymphoma

Upload

P. Kottaridis, K. Thomson, A. Cassoni, R. Pearce, R. Chakraverty, Emma C. Morris

, K. Peggs, S. Mackinnon

Myeloablative allogeneic stem cell transplantation with unrelated donors for high-risk acute myeloid leukaemia: no increase in relapse with alemtuzumab-depleted grafts

Upload

D. P. Hart, S.-A. Xue, S. Thomas, M. Cesco Gaspere, A. Tranter, B. Willcox, S. P. Lee, N. Steven, E. C. Morris

, H. J. Stauss

Retroviral transfer of a dominant TCR prevents surface expression of a large proportion of the endogenous TCR repertoire in human T cells

Download from www.nature.com

Hj Stauss, Sharyn Thomas, Michela Cesco-Gaspere, Dp Hart, Sa Xue, Angelika Holler, Judy King, Graham Wright, Mario Perro, Constantina Pospori, Emma Morris

WT1-specific T cell receptor gene therapy: Improving TCR function in transduced T cells

Upload

Kj J. Thomson, Ks S. Peggs, P. Smith, James Cavet, Ann Hunter, Anne Parker, Ruth Pettengell, Donald W. Milligan, Pr Parker A., Ec C. Morris

, Mec Milligan D., Ah H. Goldstone, Ldc Goldstone Ah, Dc C. Linch, Stephen Mackinnon

Superiority of reduced intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin’s lymphoma following autologous stem cell transplantation.

Download from www.nature.com

2007 Kirsty Thomson, Emma C. Morris

, Donald Milligan, Ann Hunter, Gordon Cook, Adrian Bloor, Charles Craddock, Lynny Yung, Anne Parker, Ronjon Chakraverty, Karl Peggs, Stephen Mackinnon

Extended follow-up of reduced intensity transplantation with an alemtuzumab-containing regimen for follicular lymphoma

Upload

Daniel P. Hart, Sharyn Thomas, Shao-An Xue, Emma C. Morris

, Hans J. Stauss

LMP2-Specific TCR Gene Therapy for Hodgkin Lymphoma - Design of a Dominant TCR Construct for Immunotherapy.

Upload

Kirsty Thomson, Emma C. Morris

, Adrian Bloor, Gordon Cook, Donald Milligan, Anne Parker, Charles Craddock, Lynny Yung, Ronjon Chakraverty, Karl Peggs, Stephen Mackinnon

Long-term follow-up of reduced intensity transplantation with an alemtuzumab-containing regimen for aggressive non-Hodgkins lymphoma

Upload

Ronjon Chakraverty, Nilusha Manji, Richard Clark, Charles Crawley, Peter Johnson, Effie Liakopoulou, Judith Marsh, Donald Milligan, Emma Morris

, Karl Peggs, Kirsty Thomson, John Snowden, Graham Jackson, Stephen Mackinnon

Multi-center phase II study of CAMPATH-1H dose de-escalation prior to nonmyeloablative HLA-identical sibling transplantation

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Emma C. Morris